Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
-
- Steven J. Chadban
- Royal Prince Alfred Hospital and Charles Perkins Centre, University of Sydney, Sydney, Australia.
-
- Curie Ahn
- Seoul National University, Seoul, South Korea.
-
- David A. Axelrod
- University of Iowa, Iowa City, IA, USA.
-
- Bethany J. Foster
- The Montreal Children’s Hospital, McGill University Health Centre, Montreal, Canada.
-
- Bertram L. Kasiske
- Hennepin County Medical Center, Minneapolis, MN, USA.
-
- Vijah Kher
- Medanta Kidney and Urology Institute, Haryana, India.
-
- Deepali Kumar
- University Health Network, University of Toronto, Toronto, Canada.
-
- Rainer Oberbauer
- Medical University of Vienna, Vienna, Austria.
-
- Julio Pascual
- Hospital del Mar, Barcelona, Spain.
-
- Helen L. Pilmore
- Auckland City Hospital, Auckland, New Zealand.
-
- James R. Rodrigue
- Beth Israel Deaconess Medical Center, Boston, MA, USA.
-
- Dorry L. Segev
- Johns Hopkins University School of Medicine, Baltimore, MD, USA.
-
- Neil S. Sheerin
- Newcastle University, Newcastle, UK.
-
- Kathryn J. Tinckam
- University Health Network, University of Toronto, Toronto, Canada.
-
- Germaine Wong
- University of Sydney, Sydney, Australia.
-
- Ethan M. Balk
- Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI, USA.
-
- Craig E. Gordon
- Tufts Medical Center, Boston, MA, USA.
-
- Amy Earley
- Evidera, Waltham, MA, USA.
-
- Valerie Rofeberg
- Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI, USA.
-
- Gregory A. Knoll
- The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada.
抄録
<jats:p>The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual’s suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate’s profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence. The strengths of recommendations are provided in the full report. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.</jats:p>
収録刊行物
-
- Transplantation
-
Transplantation 104 (4), 708-714, 2020-04
Ovid Technologies (Wolters Kluwer Health)